Shares of Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) saw an uptick in trading volume on Thursday. Approximately 6,357 shares were traded during mid-day trading, an increase of 777% from the previous session’s volume of 725 shares. The stock last traded at $46.90 and had previously closed at $45.77.
Orion OYJ Stock Performance
The company has a quick ratio of 1.48, a current ratio of 2.64 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $13.24 billion, a PE ratio of 19.30 and a beta of 0.07. The business has a 50 day simple moving average of $45.21 and a 200 day simple moving average of $41.03.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last released its earnings results on Friday, July 17th. The company reported $0.58 EPS for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%. The company had revenue of $606.38 million during the quarter.
Orion OYJ Company Profile
Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.
The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas.
See Also
- Five stocks we like better than Orion OYJ
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
